Better Antidepressant Efficacy of Mecamylamine in Combination With L-Name Than With L-Arginine Publisher Pubmed



Ebrahimighiri M¹ ; Mohammadimahdiabadihasani MH² ; Nasehi M³ ; Zarrindast MR^{4, 5, 6, 7} Show Affiliations
Source: Behavioural Brain Research Published:2020

Abstract

Aff ;ective disorders, including anxiety and mood disorders, are a constellation of psychiatric diseases that aff ;ect over 10 % of the world's population. It has been proposed that drugs that change nicotinic acetylcholine receptor (nAChR) activity can affect mood- and anxiety-related behaviors. Also, neuronal nitric oxide synthase (nNOS) is closely associated with the pathophysiology of these disorders. To limit the potential adverse effects of alteration in cholinergic and nitric oxide (NO) systems, we investigated the combined efficacy of subthreshold doses of nAChR antagonist mecamylamine and NO ligands (L-arginine as agonist and L-NAME as an antagonist) on depression- and anxiety-related behaviors in male NMRI mice. Depression-related behaviors using the forced swim test (FST) and anxiety-like activity using the hole-board test were assessed. In our results, mecamylamine (3 mg/kg) showed antidepressant-like properties, and it also tended to have anxiolytic-like effects, though not significant. Concomitant treatment of subthreshold doses of mecamylamine (1 mg/kg) and L-arginine (25 mg/kg), L-NAME (1 mg/kg), or L-arginine/L-NAME were antidepressive. In contrast, L-arginine/L-NAME alone or in associated with mecamylamine showed anxiogenic-like efficacy. Isobolographic analysis exhibited an additive antidepressant effect of the combined subthreshold doses of mecamylamine and L-arginine, and a synergistic antidepressant effect of the combined subthreshold doses of mecamylamine and L-NAME. It should be noted that mecamylamine (3 mg/kg) elicited hypolocomotion. Our results suggest that mecamylamine produces a better antidepressant efficacy in combination with L-NAME than with L-arginine. © 2020